JNJ · News · 20260806N

Accrued Legal and Regulatory

JOHNSON & JOHNSON · 2026-08-06 · Importance 71 · Surprise 60

Johnson & Johnson agreed to a $5.5 billion settlement covering tens of thousands of talc baby-powder lawsuits. The settlement is intended to resolve decades of litigation concerning alleged health risks from talc products. The agreement could reduce uncertainty around future litigation-related cash demands, although the financial timing depends on settlement participation and implementation. The matter relates to J&J's legacy consumer-health products rather than its current Innovative Medicine and MedTech revenue segments.

Key facts